Mark K Fung

Summary

Affiliation: University of Vermont
Country: USA

Publications

  1. ncbi Severe hemolysis resulting from D incompatibility in a case of ABO-identical liver transplant
    Mark K Fung
    Department of Pathology, University of Pittsburgh School of Medicine, Pennsylvania, USA
    Transfusion 44:1635-9. 2004
  2. ncbi Clinical effects of reverting from leukoreduced to nonleukoreduced blood in cardiac surgery
    Mark K Fung
    Department of Pathology, University of Vermont, Burlington, VT, USA
    Transfusion 46:386-91. 2006
  3. ncbi Transfusion of platelets containing ABO-incompatible plasma: a survey of 3156 North American laboratories
    Mark K Fung
    Department of Pathology, Fletcher Allen Health Care, 111 Colchester Ave, Burlington, VT 05401, USA
    Arch Pathol Lab Med 131:909-16. 2007
  4. ncbi A proposal for curriculum content in transfusion medicine and blood banking education in pathology residency programs
    Mark K Fung
    Department of Pathology and Laboratory Medicine, Fletcher Allen Health Care, 111 Colchester Avenue, Burlington, VT 05401, USA
    Transfusion 47:1930-6. 2007
  5. ncbi Platelet-white blood cell (WBC) interaction, WBC apoptosis, and procoagulant activity in stored red blood cells
    Friederike K Keating
    Department of Medicine, University of Vermont, Burlington, Vermont, USA
    Transfusion 51:1086-95. 2011
  6. ncbi Leukoreduction in the setting of open heart surgery: a prospective cohort-controlled study
    Mark K Fung
    Department of Pathology, University of Pittsburgh School of Medicine, USA
    Transfusion 44:30-5. 2004
  7. ncbi Induction of platelet white blood cell (WBC) aggregate formation by platelets and WBCs in red blood cell units
    Friederike K Keating
    Department of Medicine and Pathology and Laboratory Medicine, University of Vermont, Burlington, VT 05401, USA
    Transfusion 48:1099-105. 2008
  8. ncbi Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions
    Erin G Brooks
    Department of Pathology, University of Vermont and Fletcher Allen Health Care, Burlington, Vermont 05401, USA
    Transfusion 48:2159-66. 2008

Detail Information

Publications8

  1. ncbi Severe hemolysis resulting from D incompatibility in a case of ABO-identical liver transplant
    Mark K Fung
    Department of Pathology, University of Pittsburgh School of Medicine, Pennsylvania, USA
    Transfusion 44:1635-9. 2004
    ..Approximately 10 percent of ABO-compatible liver transplants involve a D- donor and a D+ recipient...
  2. ncbi Clinical effects of reverting from leukoreduced to nonleukoreduced blood in cardiac surgery
    Mark K Fung
    Department of Pathology, University of Vermont, Burlington, VT, USA
    Transfusion 46:386-91. 2006
    ..Follow-up data are now presented in a similar population after a 12-month period in which LR blood was no longer routinely used...
  3. ncbi Transfusion of platelets containing ABO-incompatible plasma: a survey of 3156 North American laboratories
    Mark K Fung
    Department of Pathology, Fletcher Allen Health Care, 111 Colchester Ave, Burlington, VT 05401, USA
    Arch Pathol Lab Med 131:909-16. 2007
    ..However, limited data describe the extent to which transfusion services manage such platelet transfusions or the methods used to limit the risk of such reactions...
  4. ncbi A proposal for curriculum content in transfusion medicine and blood banking education in pathology residency programs
    Mark K Fung
    Department of Pathology and Laboratory Medicine, Fletcher Allen Health Care, 111 Colchester Avenue, Burlington, VT 05401, USA
    Transfusion 47:1930-6. 2007
  5. ncbi Platelet-white blood cell (WBC) interaction, WBC apoptosis, and procoagulant activity in stored red blood cells
    Friederike K Keating
    Department of Medicine, University of Vermont, Burlington, Vermont, USA
    Transfusion 51:1086-95. 2011
    ..The aim of this study was to characterize PLT-WBC interactions (PLT-WBC aggregates [PLAs]), WBC apoptosis, WBC death, and the development of procoagulant activity in RBCs during storage...
  6. ncbi Leukoreduction in the setting of open heart surgery: a prospective cohort-controlled study
    Mark K Fung
    Department of Pathology, University of Pittsburgh School of Medicine, USA
    Transfusion 44:30-5. 2004
    ..The mechanisms through which these changes in clinical outcomes are generated remain unknown...
  7. ncbi Induction of platelet white blood cell (WBC) aggregate formation by platelets and WBCs in red blood cell units
    Friederike K Keating
    Department of Medicine and Pathology and Laboratory Medicine, University of Vermont, Burlington, VT 05401, USA
    Transfusion 48:1099-105. 2008
    ..Transfusion of red blood cell (RBC) preparations is independently associated with adverse clinical outcomes in patients with acute cardiovascular disease. This study was designed to define mechanisms potentially contributing...
  8. ncbi Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions
    Erin G Brooks
    Department of Pathology, University of Vermont and Fletcher Allen Health Care, Burlington, Vermont 05401, USA
    Transfusion 48:2159-66. 2008
    ..HLAMatchmaker (HLAMM) is an algorithm that determines donor-recipient histocompatibility based on HLA type. This study determines the effectiveness of HLAMM in identifying suitable platelet (PLT) donors for refractory patients...